Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study
<p dir="ltr">Background: The use of anticoagulant bridging remains controversial. This study was conducted to evaluate our warfarin periprocedural management in Qatar and investigate the associated clinical outcomes with such management. Methods: A prospective cohort study was design...
محفوظ في:
| المؤلف الرئيسي: | Islam Eljilany (14151588) (author) |
|---|---|
| مؤلفون آخرون: | Mohamed Elarref (17316937) (author), Nabil Shallik (15900256) (author), Abdel-Naser Elzouki (9376853) (author), AbdulMoqeeth Mohammed (14151621) (author), Bassam Shoman (17316940) (author), Sami Ibrahim (17316943) (author), Cornelia Carr (17316946) (author), Daoud Al-Badriyeh (832403) (author), Larisa H. Cavallari (7943018) (author), Hazem Elewa (3592601) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey
حسب: Islam Eljilany (14151588)
منشور في: (2022) -
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)
حسب: Amr M. Fahmi (21632909)
منشور في: (2024) -
Effect of SAMe-TT<sub>2</sub>R<sub>2</sub> score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
حسب: Hazem Elewa (3592601)
منشور في: (2020) -
Evaluation of warfarin management in primary health care centers in Qatar: A retrospective cross-sectional analysis of the national dataset
حسب: Safaa Alshihab (21633677)
منشور في: (2024) -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
حسب: Islam, Eljilany
منشور في: (2022)